(Q39635805)

13 September 2017

title

Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy (English)

1 reference

13 September 2017

1 reference

5

Hans R Figulla

1 reference

13 September 2017

Michael Fritzenwanger

4

object named as

Michael Fritzenwanger

1 reference

13 September 2017

Buntaro Fujita

1

1 reference

13 September 2017

Marcus Franz

2

1 reference

13 September 2017

Bjoern Goebel

3

1 reference

13 September 2017

Friedhelm Kuethe

6

1 reference

13 September 2017

Markus Ferrari

7

1 reference

13 September 2017

Christian Jung

8

1 reference

13 September 2017

publication date

28 March 2012

1 reference

Clinical Research in Cardiology

13 September 2017

published in

1 reference

13 September 2017

volume

101

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

701-707

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-012-0447-z

13 September 2017

exact match

0 references

cites work

Medical therapy for chronic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Heart rate reduction in cardiovascular disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Ivabradine for the treatment of stable angina pectoris in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Health status as a risk factor in cardiovascular disease: a systematic review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

The pathology of cardiomyopathies. A critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Dilated cardiomyopathy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Dilated cardiomyopathy: diagnostic accuracy of endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Discriminant properties of commonly used quality of life measures in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Chronic heart failure: current evidence, challenges to therapy, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Cardiovascular mortality in hypertensive men according to presence of associated risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Impact of obesity on quality of life and depression in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0447-Z

Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy

21 January 2018

1 reference

12 December 2020

Dilated cardiomyopathy: emerging role of endomyocardial biopsy.

1 reference

12 December 2020

Impact of diabetes mellitus on quality of life in patients with congestive heart failure.

1 reference

12 December 2020

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

12 December 2020

Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND.

1 reference

12 December 2020

Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?

1 reference

12 December 2020

Resting heart rate and cardiac function in dilated cardiomyopathy

1 reference

12 December 2020

10.1007/S00392-012-0447-Z

Identifiers

DOI

1 reference

13 September 2017

1 reference